SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001279569-16-003090
Filing Date
2016-04-01
Accepted
2016-04-01 07:52:07
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 40-F/A v435883_40fa.htm 40-F/A 25867
2 EXHIBIT 1.2 v435883_ex1-2.htm EX-1.2 378408
3 EXHIBIT 23.1 v435883_ex23-1.htm EX-23.1 5760
4 EXHIBIT 31.1 v435883_ex31-1.htm EX-31.1 17578
5 EXHIBIT 32.1 v435883_ex32-1.htm EX-32.1 4623
6 GRAPHIC image_001.jpg GRAPHIC 2457
7 GRAPHIC image_002.jpg GRAPHIC 3378
8 GRAPHIC tex23-1pg1.jpg GRAPHIC 6852
9 GRAPHIC tex23-1pg2.jpg GRAPHIC 6326
  Complete submission text file 0001279569-16-003090.txt   460087
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 40-F/A | Act: 34 | File No.: 000-29338 | Film No.: 161545055
SIC: 2834 Pharmaceutical Preparations